Who pays for the medical costs of obesity? New evidence from the employer mandate

2018 ◽  
Vol 27 (12) ◽  
pp. 2016-2029 ◽  
Author(s):  
Conor Lennon
Keyword(s):  
Medical Costs ◽  
New Evidence ◽  
Employer Mandate

scholarly journals How Does Risk Selection Respond to Risk Adjustment? New Evidence from the Medicare Advantage Program

2014 ◽  
Vol 104 (10) ◽  
pp. 3335-3364 ◽  
Author(s):  
Jason Brown ◽  
Mark Duggan ◽  
Ilyana Kuziemko ◽  
William Woolston
Keyword(s):  
Adverse Selection ◽  
Risk Adjustment ◽  
Medical Costs ◽  
Risk Selection ◽  
Health Plans ◽  
Medicare Advantage ◽  
Capitation Payments ◽  
New Evidence

To combat adverse selection, governments increasingly base payments to health plans and providers on enrollees' scores from risk-adjustment formulae. In 2004, Medicare began to risk-adjust capitation payments to private Medicare Advantage (MA) plans to reduce selection-driven overpayments. But because the variance of medical costs increases with the predicted mean, incentivizing enrollment of individuals with higher scores can increase the scope for enrolling “overpriced” individuals with costs significantly below the formula's prediction. Indeed, after risk adjustment, MA plans enrolled individuals with higher scores but lower costs conditional on their score. We find no evidence that overpayments were on net reduced. (JEL G22, H51, I13, I18)

Systematic effects in observed parallaxes

1978 ◽  
Vol 48 ◽  
pp. 31-35
Author(s):  
R. B. Hanson
Keyword(s):  
Error Estimates ◽  
Zero Point ◽  
Absolute Zero ◽  
Apparent Magnitude ◽  
Coherent System ◽  
Preliminary Results ◽  
General Catalogue ◽  
Systematic Effects ◽  
New Evidence ◽  
Right Ascension

Several outstanding problems affecting the existing parallaxes should be resolved to form a coherent system for the new General Catalogue proposed by van Altena, as well as to improve luminosity calibrations and other parallax applications. Lutz has reviewed several of these problems, such as: (A) systematic differences between observatories, (B) external error estimates, (C) the absolute zero point, and (D) systematic observational effects (in right ascension, declination, apparent magnitude, etc.). Here we explore the use of cluster and spectroscopic parallaxes, and the distributions of observed parallaxes, to bring new evidence to bear on these classic problems. Several preliminary results have been obtained.

Patients Who Skipped Care Blamed High Medical Costs

2011 ◽  
Vol 42 (4) ◽  
pp. 49
Author(s):  
MARY ELLEN SCHNEIDER
Keyword(s):  
Medical Costs

MERLIN Finds New Evidence of Ranolazine Safety

2007 ◽  
Vol 40 (9) ◽  
pp. 36
Author(s):  
BRUCE JANCIN
Keyword(s):  
New Evidence

Vaccination for travellers – new evidence and recommendations

2001 ◽  
Vol 58 (6) ◽  
pp. 362-366 ◽  
Author(s):  
Matius P. Stürchler ◽  
R. P. Steffen
Keyword(s):  
Hepatitis B ◽  
Hepatitis A ◽  
New Evidence

Impfungen sind einfache und effektive Maßnahmen zur Verhinderung von Reisekrankheiten. Compliance-Probleme sind gering, da alle Impfungen noch vor Abreise verabreicht werden und bei manchen Impfungen nur eine Dosis für den zuverlässigen Schutz nötig ist. Für jeden Reisenden sind die Hepatitis A- und die Diphtherie-Tetanus-Impfung empfohlen, für Asien und Afrika auch die Polioimpfung. Bei Reisen >30 Tagen, jüngeren Personen und Reisenden mit Risikoverhalten sollte immer auch eine Hepatitis B-Impfung, eventuell als Kombination mit Hepatitis A in Betracht gezogen werden. Je nach Reisestil, -destination und -dauer können auch weitere Impfungen wie z.B. die Typhus-, Tollwut-, Zeckenenzephalitis-, Grippe-, Masern-Mumps-Röteln-, Gelbfieber-, Meningokokkenmeningitis- und die Japanische Enzephalitis-Impfung in Frage kommen. Mehrere Impfungen können gleichzeitig verabreicht werden – eine Staffelung ist nicht nötig. i BAG Supplementum VI, Stand Juli 2000 «Impfungen für Auslandreisende»; http://www.admin.ch/bag/infekt/prev/reisemed/index.htm; Safetravel http://www.safetravel.ch; Tropimed

Strategic control of a time criterion in naming: New evidence and effects

1997 ◽  
Author(s):  
Stephen J. Lupker ◽  
Tamsen E. Taylor ◽  
Penny M. Pexman
Keyword(s):  
Strategic Control ◽  
Time Criterion ◽  
New Evidence
Sign in / Sign up

Export Citation Format

Share Document